Quinazoline Derivatives For The Treatment Of Cancer Diseases

Abstract

The present invention relates to the use of quinazolines of formula (I), wherein the groups R a to R d have the meanings given in the claims and specification, in cancer therapy.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jan 10, 2017
  • Application: Jun 15, 2015
    US US 201514739299 A
  • Priority: Jun 15, 2015
    US US 201514739299 A
  • Priority: Feb 14, 2013
    US US 201313766914 A
  • Priority: Sep 9, 2008
    US US 9332108 A
  • Priority: Nov 9, 2006
    EP EP 2006068313 W
  • Priority: Nov 11, 2005
    EP EP 05110656 A

Download Citation


Sign in to the Lens

Feedback